Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01496014 · ClinicalTrials.gov registry record
Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage
A clinical trial of Open Fracture, sponsored by Major Extremity Trauma Research Consortium.
- Completed
- Registry status
- 600
- Enrollment target
- 20
- Study locations
NCT01496014 is a study of Open Fracture that has completed, run by Major Extremity Trauma Research Consortium. The registered enrollment target is 600 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT01496014, a study of Open Fracture, has completed, sponsored by Major Extremity Trauma Research Consortium.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to characterize the bacteria in the wound "bioburden" at the time of definitive wound coverage/closure of severe tibia fractures in both the military and civilian populations.
Conditions Studied
Study Locations (20)
Maryland
- University of Maryland, R Adams Cowley Shock Trauma Center - Baltimore
- Walter Reed Military Medical Center - Bethesda
- Walter Reed National Military Medical Center - Bethesda
California
- Naval Medical Center San Diego - San Diego
- UCSF Medical Center - San Francisco
Florida
- University of Miami Ryder Trauma Center - Miami
- Florida Orthopaedic Institute - Tampa
Minnesota
- Hennepin County Medical Center / Minneapolis - Minneapolis
- Regions Hospital - Saint Paul
Missouri
- Barnes Jewish Hospital - St Louis
- St. Louis Medical Center - St Louis
Colorado
- Denver Health and Hospital Authority - Denver
Georgia
- Emory University Dept of Orthopaedics - Atlanta
Indiana
- OrthoIndy at St Vincent - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2011-09 |
| Est. Completion | 2022-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01496014
The ClinicalTrials.gov registry entry for NCT01496014 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Major Extremity Trauma Research Consortium, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Open Fracture appearing as the primary indexed condition, and to 0 interventions.
NCT01496014 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Maryland, California, Florida.
Frequently Asked Questions
What is clinical trial NCT01496014 about?
NCT01496014 is a clinical study titled "Assessment of Severe Extremity Wound Bioburden at the Time of Definitive Wound Closure or Coverage". The purpose of this study is to characterize the bacteria in the wound "bioburden" at the time of definitive wound coverage/closure of severe tibia fractures in both the military and civilian populations.
What is the current status of trial NCT01496014?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2011-09. Estimated completion is 2022-06-30.
What conditions does trial NCT01496014 study?
This clinical trial studies the following conditions: Open Fracture.
Who is sponsoring clinical trial NCT01496014?
This trial is sponsored by Major Extremity Trauma Research Consortium, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01496014 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Open Fracture
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.